Budesonide Inhalation Suspension
Product Images NDC 68180-984

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Budesonide Inhalation (NDC 68180-984). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 01

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 02

This text presents data on the mean change from baseline in nighttime asthma symptoms for patients undergoing different treatments over a 12-week period. The treatments included a placebo and three different doses (0.25mg, 0.5mg, and 1.0mg) of a medication administered once daily. The results show that all three medication doses led to statistically significant reductions in nighttime asthma symptoms compared to the placebo. The p-values suggest that the 0.25mg dose was the most effective treatment with the lowest p-value of 0.001.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 03

The text describes a chart that shows the mean change from baseline in nighttime asthma symptoms over a 12 week period. The chart displays the results from a placebo and two different dosages of a medication. The medication dosages are 0.25 mg and 0.5 mg, both taken twice daily. The chart indicates that both medication dosages resulted in statistically significant reductions in nighttime asthma symptoms compared to placebo, with p-values of 0.022 and 0.021 for the two dosages.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 04

The text provides data on the mean change from baseline for nighttime asthma symptoms for different dosage levels of a medication over a 12-week period. The medication was administered at different doses, once or twice daily, and placebo was also included. The p-values are provided for each dosage level.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 05

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 06

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 07

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 08

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 09

This appears to be a mix of different pieces of text without a clear context. Therefore, it's not possible to generate a useful description.*

FDA Label Image

E986c849 75fc 4c78 B593 1bd0c878adf8 10

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.